Structural basis of resistance to anti-cytochrome bc₁ complex inhibitors: implication for drug improvement

Area of Science:

• Biochemistry
• Drug Discovery
• Structural Biology

Background:

• Drug resistance to cytochrome bc₁ complex inhibitors poses significant economic and social burdens.
• Mutations in the cytochrome b subunit, alternative ubiquinol oxidation pathways, and pharmacokinetics contribute to resistance.
• Developing novel bc₁ inhibitors with reduced resistance potential is a key research area.

Purpose of the Study:

• To review structural data of cytochrome bc₁ complexes with bound inhibitors.
• To analyze inhibitor binding modes and conformational changes.
• To identify reasons for inhibitor failure and propose alternative strategies.

Main Methods:

• Compilation and analysis of crystallographic data for cytochrome bc₁ complexes.
• Examination of inhibitor binding sites (quinol oxidation and quinone reduction sites).
• Assessment of conformational changes in active site side chains and domain movements.

Main Results:

• Detailed structural insights into inhibitor binding at distinct active sites.
• Understanding of how specific mutations and conformational changes lead to resistance.
• Identification of structural features contributing to the failure of existing inhibitors.

Conclusions:

• Structural analysis provides a basis for rational design of new bc₁ inhibitors.
• Targeting specific binding sites and understanding resistance mechanisms can guide the development of more effective drugs.
• Future drug design should consider novel binding modes to overcome existing resistance patterns.